While insurers negotiate steep discounts on medicines, they don’t always share these savings directly with patients. In recent years, insurers have shifted costs for brand medicines to patients by subjecting them to higher deductibles and using coinsurance rather than fixed copays. This ties the amount that patients are required to pay out-of-pocket for their medicines to the undiscounted price rather than the negotiated price their insurer gets.
